InvestorsHub Logo
Followers 43
Posts 5325
Boards Moderated 0
Alias Born 09/24/2013

Re: None

Thursday, 06/12/2014 11:11:02 AM

Thursday, June 12, 2014 11:11:02 AM

Post# of 2191
Other news: ZLCS +51.9% (Epirus Biopharmaceuticals announced positive data from a Phase 3 trial of BOW015 in patients with active rheumatoid arthritis; ZLCS entered into an agreement and plan of merger with Epirus on April 15)

Only news fees I found from briefing centre in the morning
Hoping we hear from Zalicus soon